Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $245K | $371K | $944K | $1.42M | $2.08M | $2.09M | $2.14M | $2.04M |
| Revenue growth | — | — | — | 51.1% | 154.6% | 50.7% | 46.2% | 0.3% | 2.6% | -4.8% |
| Gross profit | — | — | — | — | $316K | $554K | $750K | $862K | $743K | $566K |
| Gross margin | — | — | — | — | 33.5% | 39.0% | 36.1% | 41.3% | 34.7% | 27.8% |
| Operating income | -$151K | -$2.67M | -$3.33M | -$1.97M | -$2.60M | -$6.11M | -$4.48M | -$4.87M | -$10.3M | -$8.32M |
| Operating margin | — | — | -1358.1% | -531.4% | -275.1% | -429.7% | -215.2% | -233.6% | -480.7% | -408.4% |
| Net income | -$151K | -$2.67M | -$3.33M | -$2.72M | -$2.93M | -$6.18M | -$4.48M | -$5.49M | -$10.5M | -$8.23M |
| Net margin | — | — | -1358.1% | -734.3% | -310.8% | -434.3% | -215.6% | -263.0% | -489.9% | -404.1% |
| EPS (diluted) | -$0.01 | -$0.14 | -$0.62 | -$0.50 | -$0.51 | -$0.80 | -$0.53 | -$0.69 | -$0.99 | -$2.58 |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$148K | -$92.9K | -$1.11M | -$894K | -$297K | -$2.81M | -$2.99M | -$3.53M | -$4.63M | -$5.13M |
| Capital expenditures | — | — | $4.16K | — | — | $81.6K | $79.3K | $51.8K | $92.0K | $5.32K |
| Free cash flow | — | — | -$1.11M | — | — | -$2.89M | -$3.07M | -$3.58M | -$4.72M | -$5.14M |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $27.1K | — | $475K | $10.2K | $152K | $4.89M | $1.99M | $493K | $4.31M | $4.57M |
| Total assets | $37.7K | $165K | $2.81M | $2.20M | $9.93M | $12.7M | $9.46M | $7.52M | $7.47M | $7.55M |
| Total liabilities | $14.6K | — | — | $2.02M | $2.82M | $880K | $883K | $1.08M | $1.04M | $868K |
| Long-term debt | $1.58K | $1.82K | — | — | — | — | — | — | — | — |
| Shareholders' equity | $23.1K | $122K | $2.40M | $175K | $7.11M | $11.9M | $8.57M | $6.44M | $6.43M | $6.68M |
| Retained earnings | -$177K | -$2.85M | -$6.18M | -$8.90M | -$11.8M | -$18.0M | -$22.5M | -$28.0M | -$38.5M | -$46.7M |
| Shares (wtd avg diluted) | 15.6M | 20.9M | 5.42M | 5.44M | 5.77M | 7.93M | 8.46M | 7.95M | 10.6M | 11.6M |
Every figure is extracted from NutriBand Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.